| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/27/2002 | CN1337462A Parafin structure slice dewaxing and clearing agent |
| 02/27/2002 | CN1337405A Sodium-ion drived chlorine-ion/exchange protein bicarbonate |
| 02/27/2002 | CN1079833C Recombinant P53 adenovirus method and compositions |
| 02/27/2002 | CN1079832C Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell |
| 02/27/2002 | CN1079830C Methods and materials for treatment of individuals infected with intracellular infections agents |
| 02/26/2002 | US6350858 A polypeptide involved in controlling phosphate retention; diagnosis and therapy for chronic kidney failure, end stage kidney disease, uremic bone disease, and cancer |
| 02/26/2002 | US6350857 Fifty-four homologue (ffh) from streptococcus pneumoniae |
| 02/26/2002 | US6350855 Human interleukin-11 receptor |
| 02/26/2002 | US6350611 Transcriptional regulatory region |
| 02/26/2002 | US6350603 Phosphodiesterase 10 |
| 02/26/2002 | US6350593 Receptors for fibroblast growth factors |
| 02/26/2002 | US6350592 Aortic-specific enhancer sequence and uses thereof |
| 02/26/2002 | US6350581 Tumor-associated antigen |
| 02/26/2002 | US6350575 Helper viruses for the preparation of recombinant viral vectors |
| 02/26/2002 | US6350446 Polypeptides with amino acid sequences for kidney failure |
| 02/26/2002 | US6350445 Method of treating cancer with a tumor cell line having modified cytokine expression |
| 02/26/2002 | US6350444 Gene therapy for pulmonary edema using adenovirus vectors encoding Na,K-ATPase |
| 02/26/2002 | CA2119859C A canola variety producing a seed with reduced glucosinolates and linolenic acid yielding an oil with low sulfur, improved sensory characteristics and increased oxidative stability |
| 02/26/2002 | CA2083177C Alveolar surfactant proteins |
| 02/26/2002 | CA2079454C Steroid 5.alpha.-reductases |
| 02/25/2002 | CA2355403A1 Rapid creation of gene targeting vectors using homologous recombination in yeast |
| 02/21/2002 | WO2002014549A1 Method for combinatorial protein synthesis based on ribosomal frameshifting |
| 02/21/2002 | WO2002014546A1 Use of microbial dna sequences for the identification of human diseases |
| 02/21/2002 | WO2002014526A2 Replication competent aav helper functions |
| 02/21/2002 | WO2002014522A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | WO2002014519A1 A method to increase cerebral blood flow in amyloid angiopathy |
| 02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
| 02/21/2002 | WO2002014500A2 Human genes and gene expression products |
| 02/21/2002 | WO2002014499A2 Claudin polypeptides |
| 02/21/2002 | WO2002014494A2 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed |
| 02/21/2002 | WO2002014489A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | WO2002014485A2 Kallikrein gene |
| 02/21/2002 | WO2002014482A2 Polyketides and their synthesis |
| 02/21/2002 | WO2002014481A1 Method of extensive culture of antigen-specific cytotoxic t cells |
| 02/21/2002 | WO2002014480A2 Decellularized tissue engineered constructs and tissues |
| 02/21/2002 | WO2002014479A2 Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells |
| 02/21/2002 | WO2002014478A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY |
| 02/21/2002 | WO2002014469A2 Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells |
| 02/21/2002 | WO2002014467A2 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 02/21/2002 | WO2002014466A2 Pth analogs for renal osteodystrophy and related uses |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002014355A2 Novel mitogen activated kinase |
| 02/21/2002 | WO2002014352A2 Therapeutic compounds for ovarian cancer |
| 02/21/2002 | WO2002014348A2 Glycoproteins and methods of use thereof |
| 02/21/2002 | WO2002013760A2 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 02/21/2002 | WO2002013606A2 Improved insecticidal bacteria, and methods for making and using them |
| 02/21/2002 | WO2002013602A1 Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function |
| 02/21/2002 | WO2001081608A3 Viral vectors for use in monitoring hiv drug resistance |
| 02/21/2002 | WO2001079443A3 Albumin fusion proteins |
| 02/21/2002 | WO2001077149A3 Regulation of human cyslt2-like gpcr protein |
| 02/21/2002 | WO2001072977A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 02/21/2002 | WO2001070807A3 G-protein associated molecules |
| 02/21/2002 | WO2001066747A8 Proteins named fctrx and nucleic acids encoding same |
| 02/21/2002 | WO2001064240A3 Methods for promoting production of myelin by schwann cells |
| 02/21/2002 | WO2001062901A3 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 02/21/2002 | WO2001062899A3 Method of making embryoid bodies from primate embryonic stem cells |
| 02/21/2002 | WO2001060856A3 Vmglom gene and its mutations causing disorders with a vascular component |
| 02/21/2002 | WO2001059138A3 Plant internal ribosome entry segment |
| 02/21/2002 | WO2001059110A3 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001059076A3 Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses |
| 02/21/2002 | WO2001055391A3 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001053338A3 Cbp86, a sperm specific protein |
| 02/21/2002 | WO2001049832A3 Transduction of recombinases for inducible gene targeting |
| 02/21/2002 | WO2001046397A3 Human kinases |
| 02/21/2002 | WO2001044282A3 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 02/21/2002 | WO2001037889A3 Injectable bone-substitute material |
| 02/21/2002 | WO2001032871A3 Follistatin-related protein zfsta4 |
| 02/21/2002 | WO2001031005A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/21/2002 | WO2001023586A3 Transacylases of the paclitaxel biosynthetic pathway |
| 02/21/2002 | US20020022718 Genes identified as required for proliferation of E. coli |
| 02/21/2002 | US20020022717 Using monoclonal antibodies |
| 02/21/2002 | US20020022676 Injectable, in situ crosslinkable, biodegradable carrier for bioactive drug delivery |
| 02/21/2002 | US20020022592 Delivery of thrombospondin from implantable tissue matrices |
| 02/21/2002 | US20020022591 Polynucleotides and polypeptides comprising an ovarian tumor protein, antibodies directed against said polypeptides; diagnostic kits |
| 02/21/2002 | US20020022270 Human tissue cultures; inoculate vessel containing stromal tissue, continuously perfuse issue with nutrient broth, harvest preferential human tissue |
| 02/21/2002 | US20020022269 Hematology composition using preserved white blood cells in combination with source particles to simulate native white blood cells and method of making same |
| 02/21/2002 | US20020022268 Culturing primate progenitor tissues; obtain tissues, harvest nutrients from culture, monitor tissue propagation |
| 02/21/2002 | US20020022267 Methods of culturing embryonic stem cells and controlled differentiation |
| 02/21/2002 | US20020022259 Cardiac-cell specific enhancer elements and uses thereof |
| 02/21/2002 | US20020022254 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 02/21/2002 | US20020022216 Preferential propagation of target cells; mix cells with propagation nutrients, monitor cell propagtion, recover preferential cells |
| 02/21/2002 | US20020022214 Reproductive cultures containing colloidal silver |
| 02/21/2002 | US20020022213 Treating an environmental site with an effective amount of a composition comprising one or more hydrogenotrophic bacteria and zero-valent iron |
| 02/21/2002 | US20020022033 Diagnosis of Aids |
| 02/21/2002 | US20020022029 Human RRP sequences and methods of use |
| 02/21/2002 | US20020022027 Complexing to polypeptides; antiproliferation agent |
| 02/21/2002 | US20020022020 Induction lymphocyte tolerance |
| 02/21/2002 | DE10038700A1 Autologe Bindegewebe, Verfahren zu ihrer Herstellung und ihre Verwendung Autologous connective tissue, processes for their preparation and their use |
| 02/21/2002 | DE10038382A1 Zweifarbiges fluorimetrisches Proteaseassay Two-toned fluorometric protease assay |
| 02/21/2002 | DE10036671A1 New nucleic acid encoding mitochondrial transporter, useful for preparing transgenic plants with e.g. altered protein content and improved germination |
| 02/21/2002 | CA2423592A1 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 02/21/2002 | CA2420037A1 Immunogenic hbc chimer particles having enhanced stability |
| 02/21/2002 | CA2419817A1 Decellularized tissue engineered constructs and tissues |
| 02/21/2002 | CA2419538A1 Polyketides and their synthesis |
| 02/21/2002 | CA2419505A1 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed |
| 02/21/2002 | CA2419491A1 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | CA2419157A1 Improved insecticidal bacteria, and methods for making and using them |
| 02/21/2002 | CA2419020A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | CA2418725A1 Claudin polypeptides |
| 02/21/2002 | CA2418266A1 Novel mitogen activated kinase |